BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30383205)

  • 1. Maximum Reading Speed in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration.
    Varma R; Souied EH; Tufail A; Tschosik E; Ferrara D; Zhang J; Silverman D; Dolan C; Bressler NM
    Invest Ophthalmol Vis Sci; 2018 Mar; 59(4):AMD195-AMD201. PubMed ID: 30383205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration: Chroma and Spectri Phase 3 Randomized Clinical Trials.
    Holz FG; Sadda SR; Busbee B; Chew EY; Mitchell P; Tufail A; Brittain C; Ferrara D; Gray S; Honigberg L; Martin J; Tong B; Ehrlich JS; Bressler NM;
    JAMA Ophthalmol; 2018 Jun; 136(6):666-677. PubMed ID: 29801123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Reading Independence (FRI) Index: A New Patient-Reported Outcome Measure for Patients With Geographic Atrophy.
    Kimel M; Leidy NK; Tschosik E; Dolan C; Souied EH; Varma R; Bressler NM
    Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6298-6304. PubMed ID: 27893095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability and Construct Validity of the NEI VFQ-25 in a Subset of Patients With Geographic Atrophy From the Phase 2 Mahalo Study.
    Sivaprasad S; Tschosik E; Kapre A; Varma R; Bressler NM; Kimel M; Dolan C; Silverman D
    Am J Ophthalmol; 2018 Jun; 190():1-8. PubMed ID: 29530781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual Function Decline Resulting from Geographic Atrophy: Results from the Chroma and Spectri Phase 3 Trials.
    Heier JS; Pieramici D; Chakravarthy U; Patel SS; Gupta S; Lotery A; Lad EM; Silverman D; Henry EC; Anderesi M; Tschosik EA; Gray S; Ferrara D; Guymer R;
    Ophthalmol Retina; 2020 Jul; 4(7):673-688. PubMed ID: 32199866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.
    Liao DS; Grossi FV; El Mehdi D; Gerber MR; Brown DM; Heier JS; Wykoff CC; Singerman LJ; Abraham P; Grassmann F; Nuernberg P; Weber BHF; Deschatelets P; Kim RY; Chung CY; Ribeiro RM; Hamdani M; Rosenfeld PJ; Boyer DS; Slakter JS; Francois CG
    Ophthalmology; 2020 Feb; 127(2):186-195. PubMed ID: 31474439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration.
    Fleckenstein M; Mitchell P; Freund KB; Sadda S; Holz FG; Brittain C; Henry EC; Ferrara D
    Ophthalmology; 2018 Mar; 125(3):369-390. PubMed ID: 29110945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of incident geographic atrophy in the complications of age-related macular degeneration prevention trial.
    Brader HS; Ying GS; Martin ER; Maguire MG;
    Ophthalmology; 2013 Sep; 120(9):1871-9. PubMed ID: 23622873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
    Heier JS; Lad EM; Holz FG; Rosenfeld PJ; Guymer RH; Boyer D; Grossi F; Baumal CR; Korobelnik JF; Slakter JS; Waheed NK; Metlapally R; Pearce I; Steinle N; Francone AA; Hu A; Lally DR; Deschatelets P; Francois C; Bliss C; Staurenghi G; Monés J; Singh RP; Ribeiro R; Wykoff CC;
    Lancet; 2023 Oct; 402(10411):1434-1448. PubMed ID: 37865470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Clinical Trial.
    Rosenfeld PJ; Dugel PU; Holz FG; Heier JS; Pearlman JA; Novack RL; Csaky KG; Koester JM; Gregory JK; Kubota R
    Ophthalmology; 2018 Oct; 125(10):1556-1567. PubMed ID: 29716784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PHASE 2 STUDY OF THE SAFETY AND EFFICACY OF BRIMONIDINE DRUG DELIVERY SYSTEM (BRIMO DDS) GENERATION 1 IN PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
    Kuppermann BD; Patel SS; Boyer DS; Augustin AJ; Freeman WR; Kerr KJ; Guo Q; Schneider S; López FJ;
    Retina; 2021 Jan; 41(1):144-155. PubMed ID: 32134802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Reading Performance in Geographic Atrophy Secondary to Age-Related Macular Degeneration With Visual Function and Structural Biomarkers.
    Künzel SH; Lindner M; Sassen J; Möller PT; Goerdt L; Schmid M; Schmitz-Valckenberg S; Holz FG; Fleckenstein M; Pfau M
    JAMA Ophthalmol; 2021 Nov; 139(11):1191-1199. PubMed ID: 34591067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling Visual Acuity in Geographic Atrophy Secondary to Age-Related Macular Degeneration.
    Schmitz-Valckenberg S; Nadal J; Fimmers R; Lindner M; Holz FG; Schmid M; Fleckenstein M;
    Ophthalmologica; 2016; 235(4):215-24. PubMed ID: 27089126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration.
    Yaspan BL; Williams DF; Holz FG; Regillo CD; Li Z; Dressen A; van Lookeren Campagne M; Le KN; Graham RR; Beres T; Bhangale TR; Honigberg LA; Smith A; Henry EC; Ho C; Strauss EC;
    Sci Transl Med; 2017 Jun; 9(395):. PubMed ID: 28637922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of Reading Performance in Eyes with Foveal-Sparing Geographic Atrophy.
    Lindner M; Pfau M; Czauderna J; Goerdt L; Schmitz-Valckenberg S; Holz FG; Fleckenstein M
    Ophthalmol Retina; 2019 Mar; 3(3):201-210. PubMed ID: 31014695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and microperimetric predictors of reading speed in low vision patients: a structural equation modeling approach.
    Giacomelli G; Virgili G; Giansanti F; Sato G; Cappello E; Cruciani F; Varano M; Menchini U
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4403-8. PubMed ID: 23722392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographic Atrophy and Foveal-Sparing Changes Related to Visual Acuity in Patients With Dry Age-Related Macular Degeneration Over Time.
    Sayegh RG; Sacu S; Dunavölgyi R; Kroh ME; Roberts P; Mitsch C; Montuoro A; Ehrenmüller M; Schmidt-Erfurth U
    Am J Ophthalmol; 2017 Jul; 179():118-128. PubMed ID: 28385474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Evaluation of Reading Performance with Minnesota Low Vision Reading Charts in Patients with Age-related Macular Degeneration.
    Altinbay D; Adibelli FM; Taskin I; Tekin A
    Middle East Afr J Ophthalmol; 2016; 23(4):302-306. PubMed ID: 27994393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Directional kinetics analysis of the progression of geographic atrophy.
    Uji A; Nittala MG; Hariri A; Velaga SB; Sadda SR
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1679-1685. PubMed ID: 31147841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of Quality of Life in Geographic Atrophy Secondary to Age-Related Macular Degeneration.
    Künzel SH; Möller PT; Lindner M; Goerdt L; Nadal J; Schmid M; Schmitz-Valckenberg S; Holz FG; Fleckenstein M; Pfau M
    Invest Ophthalmol Vis Sci; 2020 May; 61(5):63. PubMed ID: 32462198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.